Adverse events320

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

141 to 160 of 320

Type	Event	Organ system	Group	Affected	At risk
other	Blood creatine phosphokinase increased	Investigations	Group 1 Mavacamten	0	18
other	Blood creatine phosphokinase increased	Investigations	Group 2 Mavacamten	1	21
other	Blood creatine phosphokinase increased	Investigations	Combined MAVA Treatment Group (Group 1+ Group 2)	1	39
other	Blood creatine phosphokinase increased	Investigations	Placebo	1	19
other	Blood creatinine increased	Investigations	Group 1 Mavacamten	1	18
other	Blood creatinine increased	Investigations	Group 2 Mavacamten	0	21
other	Blood creatinine increased	Investigations	Combined MAVA Treatment Group (Group 1+ Group 2)	1	39
other	Blood creatinine increased	Investigations	Placebo	0	19
other	Blood pressure abnormal	Investigations	Group 1 Mavacamten	1	18
other	Blood pressure abnormal	Investigations	Group 2 Mavacamten	0	21
other	Blood pressure abnormal	Investigations	Combined MAVA Treatment Group (Group 1+ Group 2)	1	39
other	Blood pressure abnormal	Investigations	Placebo	0	19
other	Blood urea increased	Investigations	Group 1 Mavacamten	1	18
other	Blood urea increased	Investigations	Group 2 Mavacamten	0	21
other	Blood urea increased	Investigations	Combined MAVA Treatment Group (Group 1+ Group 2)	1	39
other	Blood urea increased	Investigations	Placebo	0	19
other	Ejection fraction decreased	Investigations	Group 1 Mavacamten	1	18
other	Ejection fraction decreased	Investigations	Group 2 Mavacamten	1	21
other	Ejection fraction decreased	Investigations	Combined MAVA Treatment Group (Group 1+ Group 2)	2	39
other	Ejection fraction decreased	Investigations	Placebo	0	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03442764/events?page=8